Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9937684 | 0.95 | TYR (0.47) | TYRCYP19A1KMT2ATSHRMEN1 | |
| SCHEMBL9938471 | 0.93 | CYP19A1 (0.41) | TYRCYP19A1KMT2ATSHRMEN1 | |
| SCHEMBL9969790 | 0.92 | ALDH1A1 (0.42) | TYRKMT2ATSHRMEN1MAPT | |
| SCHEMBL9968851 | 0.90 | ALDH1A1 (0.41) | TYRKMT2ATSHRMEN1MAPT | |
| SCHEMBL9937177 | 0.87 | L3MBTL1 (0.40) | TYRKMT2ATSHRMEN1MAPT | |
| SCHEMBL24937253 | 0.86 | CYP19A1 (0.40) | TYRCYP19A1KMT2ATSHRMEN1 | |
| SCHEMBL9937438 | 0.86 | ALDH1A1 (0.39) | TYRKMT2ATSHRMEN1MAPT | |
| SCHEMBL9937665 | 0.86 | TSHR (0.41) | KMT2ATSHRMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL9937503 | 0.86 | ALDH1A1 (0.39) | KMT2ATSHRMEN1MAPTSMN1; SMN2 | |
| SCHEMBL9936606 | 0.85 | TNF (0.43) | TSHRALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2651886-B1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | ORÉAL L (FR) | 2015-03-04 | — | — | EP | claimed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | claimed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | claimed |
| EP-2651886-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'Oréal (FR) | 2013-10-23 | — | — | EP | claimed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | claimed |
| EP-3393603-B1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | OREAL (FR) | 2023-01-18 | — | — | EP | disclosed |
| US-11260000-B2 | Composition in the form of nano or micro emulsion or with lamellar structure | L'OREAL (FR) | 2022-03-01 | — | — | US | disclosed |
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | L'OREAL (FR) | 2021-10-26 | — | — | US | disclosed |
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | L'OREAL (FR) | 2021-10-26 | — | — | US | disclosed |
| EP-3171853-B1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | OREAL (FR) | 2020-07-29 | — | — | EP | disclosed |
| EP-3171853-B1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | OREAL (FR) | 2020-07-29 | — | — | EP | disclosed |
| US-20190336421-A1 | COMPOSITION COMPRISING RESORCINOL OR DERIVATIVE THEREOF | L'OREAL (FR) | 2019-11-07 | — | — | US | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| EP-2651886-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'Oréal (FR) | 2013-10-23 | — | — | EP | disclosed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | NQO1, LRAT, RBP4 | TYR 4/4885CYP19A1 20/4885KMT2A 1778/4885 |
| US-20190336421-A1 | COMPOSITION COMPRISING RESORCINOL OR DERIVATIVE THEREOF | NQO1, LRAT, RBP4 | TYR 4/4885CYP19A1 20/4885KMT2A 1778/4885 |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | KRT18, KLHL20, IK | TYR 9/4885CYP19A1 672/4885KMT2A 144/4885 |
| US-11260000-B2 | Composition in the form of nano or micro emulsion or with lamellar structure | LRAT, LIPA, DAGLA | TYR 194/4885CYP19A1 677/4885KMT2A 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.